These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 568746)

  • 1. Anamnestic studies in multiple sclerosis: a relationship between familial multiple sclerosis and neoplasia.
    Sibley WA; Bamford CR; Laguna JF
    Neurology; 1978 Sep; 28(9 Pt 2):125-8. PubMed ID: 568746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States.
    Opelz G; Terasaki P; Myers L; Ellison G; Ebers G; Zabriskie J; Weiner H; Kempe H; Sibley W
    Tissue Antigens; 1977 Jan; 9(1):54-8. PubMed ID: 850918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histocompatibility (HL-A) factors in familial multiple sclerosis. Is multiple sclerosis susceptibility inherited via the HL-A chromosome?
    Drachman DA; Davison WC; Mittal KK
    Arch Neurol; 1976 Jun; 33(6):406-13. PubMed ID: 938264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA haplotypes in families with high frequency of multiple sclerosis.
    Olsson JE; Möller E; Link H
    Arch Neurol; 1976 Dec; 33(12):808-12. PubMed ID: 999543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigen segregation analysis in multiple sclerosis (MS) families.
    Bertrams J; Kuwert E
    Z Immunitatsforsch Immunobiol; 1976 Nov; 152(3):200-8. PubMed ID: 1007375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.
    Bertrams HJ; Kuwert EK
    J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DW2, viral immunity and family studies in multiple sclerosis.
    Stewart GJ; Basten A; Guinan J; Bashir HV; Cameron J; McLeod JG
    J Neurol Sci; 1977 Jun; 32(2):153-67. PubMed ID: 874517
    [No Abstract]   [Full Text] [Related]  

  • 8. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens in multiple sclerosis.
    Thorsby E; Helgesen A; Solheim BG; Vandvik B
    J Neurol Sci; 1977 Jun; 32(2):187-93. PubMed ID: 301557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and Japanese MS.
    Naito S; Kuroiwa Y; Itoyama T; Tsubaki T; Horikawa A; Sasazuki T; Noguchi S; Ohtsuki S; Tokuomi H; Miyatake T; Takahata N; Kawanami S
    Tissue Antigens; 1978 Jul; 12(1):19-24. PubMed ID: 80838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
    Poskanzer DC; Terasaki PI; Prenney LB; Sheridan JL; Park MS
    J Epidemiol Community Health; 1980 Dec; 34(4):253-7. PubMed ID: 6972433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial multiple sclerosis: clinical, histocompatibility, and viral serological studies.
    Eldridge R; McFarland H; Sever J; Sadowsky D; Krebs H
    Ann Neurol; 1978 Jan; 3(1):72-80. PubMed ID: 418737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis.
    Alvarado-de la Barrera C; Zúñiga-Ramos J; Ruíz-Morales JA; Estañol B; Granados J; Llorente L
    Neurology; 2000 Dec; 55(12):1897-900. PubMed ID: 11134391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between HLA-Dw2 and multiple sclerosis in Israeli Jewish patients.
    Brautbar N; Lahana E; Alter M; Jorgensen F; Lamm L
    N Engl J Med; 1977 Jun; 296(26):1537-8. PubMed ID: 865542
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Multiple sclerosis susceptibility and histocompatibility determinants.
    Alter M; Harshe M; Yunis EJ
    Neurology; 1975 May; 25(5):489. PubMed ID: 1169709
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA antigens and mitogen responsiveness in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):187-9. PubMed ID: 300927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune diseases in families of French patients with multiple sclerosis.
    Heinzlef O; Alamowitch S; Sazdovitch V; Chillet P; Joutel A; Tournier-Lasserve E; Roullet E
    Acta Neurol Scand; 2000 Jan; 101(1):36-40. PubMed ID: 10660150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune disease in families with multiple sclerosis: a population-based study.
    Ramagopalan SV; Dyment DA; Valdar W; Herrera BM; Criscuoli M; Yee IM; Sadovnick AD; Ebers GC;
    Lancet Neurol; 2007 Jul; 6(7):604-10. PubMed ID: 17560172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.